Is Pfizer Inc. (PFE) the Best Stock to Invest In For Steady Dividends?
In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...
Hosted on MSN23h
Why Pfizer (PFE) Outpaced the Stock Market Today
In the latest trading session, Pfizer (PFE) closed at $26.64, marking a +1.29% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.88% for the day. Meanwhile, the ...
Takeda-backed Ascentage Pharma sets terms for $170M IPO
Takeda-backed Ascentage Pharma Group (AAPG) (ASPHF), which is developing treatments for blood cancers, has set terms for a ...
Odyssey Therapeutics Begins IPO Rollout
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...
Takeda-backed Ascentage Pharma targets $1.8 bln valuation in US IPO
Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the ...
Why Is Pfizer Inc. (PFE) Among the Best High-Yield Dividend Stocks to Invest In?
We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...
2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs
The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity ...
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, announced the selection of 15 additional ...
JPMorgan says Pfizer needs further pipeline progress to change current narrative
After catching up with Pfizer’s Chairman and CEO, CFO, Chief Scientific Officer and Chief Strategy and Innovation Officer at the firm’s healthcare conference, JPMorgan analyst ...